Navigation Links
Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
Date:10/20/2009

ile among all of the drugs in this class.

In this study, subjects underwent upper endoscopies at baseline and on day seven. Subjects receiving LT-NS001 experienced significantly fewer endoscopically-confirmed gastric ulcers compared to subjects receiving naproxen. The full results from this study will be presented at the American College of Gastroenterology meeting on October 27 in San Diego, Calif.

"In the U.S. alone, the direct costs of treating ulcer complications associated with NSAID use exceed $4 billion annually, and serious complications such as hemorrhage and perforation are directly responsible for approximately 20,000 deaths per year," Lankau said. "LT-NS001 has the potential to help bring down these costs and reduce serious complications for patients whose need for NSAID anti-inflammatory treatment is complicated by significant gastrointestinal risks."

About Logical Therapeutics Inc.

Based in Waltham, MA, Logical Therapeutics, Inc. is a venture-backed, privately held biotechnology company focused on the development of products that treat diseases associated with inflammation. Logical's investors include SV Life Sciences, Burrill and Company, Novo Ventures A/S, and Novitas Capital. For more information on Logical Therapeutics, visit the company's website at www.logicaltx.com.

Please address inquiries regarding LT-NS001 to Logical Therapeutics' business development department at bd@logicaltx.com.

SOURCE Logical Therapeutics, Inc.


'/>"/>
SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma
2. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
3. Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)
4. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
5. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
6. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
7. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
8. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
9. Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
10. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
11. The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Countrys Biological Preparedness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicald...ydisruptivesurgicaltreatmentsforthespine,announced...r30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecall...theCompany,sproductsandwillincludecommentsfrommana...dial-innumbersare1-877-407-4018fordomesticcallersa...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...ugDelivery-USMarketTrends&Analysis http://www...y---US-Market-Trends--Analysis.html ,, TheUSin...ftherapeuticapplicationsfromthedeliveryofconventio...rapeuticdrugs.Thefutureofthetechnologyhingesontoth...
(Date:11/25/2009)...PRNewswire/-- ChemoCentryx,Inc.,announcedtodaytha...theProspectiveRandomizedOralTherapyEvaluationinCro...entswithmoderate-to-severeCrohn,sdiseasedemonstrat...ityprofile.Thestudydemonstratedevidenceofclinicale...70-pointdecreaseintheCrohn,sDiseaseActivityIndex(C...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 1Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 2Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 3Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 4Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 5Heart Disease Treatment Breakthrough 4495 1Heart Disease Treatment Breakthrough 4495 2Heart Disease Treatment Breakthrough 4495 3TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 1TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 2TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 3
...ew released today by HHS, Agency for Healthcare Re...fit is lacking for many common ways of,treating os...y supplement,ingredients, a common surgical proced...that glucosamine and chondroitin, over-the-counter...ly because of their,purported benefits to relieve ...
...ty of America (IDSA) 45TH ..., Inc. today announced,results from two important ...Society of America (IDSA) 45th Annual Meeting addi...ytial virus (RSV). RSV is a viral,pathogen that pr...pring.,While RSV typically manifests cold-like sym...
Other Medicine Technology:Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 3MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 4
(Date:11/25/2009)...were treated with cisplatin-based chemotherapy had...side effects and Raynaud-like phenomena, than men ...to a new study published online November 25 in the...arianne Brydy, M.D., of the Department of Oncology..., and colleagues conducted a cross-sectional study...
(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...
(Date:11/25/2009)...s, study finds , , WEDNESDAY, Nov. 25 (...mong the potential problems faced by long-term sur...cisplatin-based chemotherapy, a new study has foun...ated for unilateral testicular cancer between 1980...ucted from 1998 to 2002. , The researchers foun...
(Date:11/25/2009)...htYear ,, WASHINGTON,Nov.25/PRNewswire-USNews...ssuedthe 4thAnnualReportCardonLungCancer .ThisRepo...aldiseaseinthestateofGeorgia.LCA-GAisachapterofLun...dicatedexclusivelytopatientsupportandadvocacyforpe...http://www.newscom.com/cgi-bin/prnh/20081016/LCALO...
(Date:11/25/2009)... cells, study finds , , WEDNESDAY, Nov. ...in a fingernail-size implant eliminated melanoma t...d uses polymer disks, 8.5 millimeters in diameter,...implanted under the skin to reprogram the immune s...entists who developed the implant predicted that i...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...ree condoms for nearly 9 months will soon be provi.../ the New York city logo as a promotional offer. M...uted since June, according to health officials. ...r would materialise in the next couple of months. ...
...cted that by 2020 road accidents will be the third...c health issues like tuberculosis, diarrhoea and H...atalities are expected to increase from 135,000 in...n' released Tuesday. Around 85 percent of th...
...tival, hot air balloon festival for 2 weeks, inaug...as been the joint efforts of Rajasthan Tourism and...ling from 11countries are participating, who will ... hot air balloons, the locale of Rajasthan making ...
...on has been confirmed in Greece, Bulgaria and Sl...ve been initiated by the Italian following detecti... br> The EU confirmed that samples sent to its ...eece. A spokesman said that in keeping with E...
...ll condoms in school through installation of condo... largest political party in Australia.// Ka... Australia's state parliament, said the issue was ...they are certainly telling their friends. We can't...
...riage) is thought to bring an increased number of ...ge lead to betterment in the health of both sexes ...y couples also offer numerous advantages. Prof...alth said that such marriages apart from health be...
Other Medicine News:Health News:Road accidents greater threat than AIDS, TB: WHO 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: